Biofabrication and biomanufacturing in Ireland and the UK
File(s)s42242-024-00316-z.pdf (8.46 MB)
Published version
Author(s)
Type
Journal Article
Abstract
As we navigate the transition from the Fourth to the Fifth Industrial Revolution, the emerging fields of biomanufacturing
and biofabrication are transforming life sciences and healthcare. These sectors are benefiting from a synergy of synthetic and
engineering biology, sustainable manufacturing, and integrated design principles. Advanced techniques such as 3D bioprinting,
tissue engineering, directed assembly, and self-assembly are instrumental in creating biomimetic scaffolds, tissues, organoids,
medical devices, and biohybrid systems. The field of biofabrication in the United Kingdom and Ireland is emerging as a pivotal
force in bioscience and healthcare, propelled by cutting-edge research and development. Concentrating on the production of
biologically functional products for use in drug delivery, in vitro models, and tissue engineering, research institutions across
these regions are dedicated to innovating healthcare solutions that adhere to ethical standards while prioritising sustainability,
affordability, and healthcare system benefits.
and biofabrication are transforming life sciences and healthcare. These sectors are benefiting from a synergy of synthetic and
engineering biology, sustainable manufacturing, and integrated design principles. Advanced techniques such as 3D bioprinting,
tissue engineering, directed assembly, and self-assembly are instrumental in creating biomimetic scaffolds, tissues, organoids,
medical devices, and biohybrid systems. The field of biofabrication in the United Kingdom and Ireland is emerging as a pivotal
force in bioscience and healthcare, propelled by cutting-edge research and development. Concentrating on the production of
biologically functional products for use in drug delivery, in vitro models, and tissue engineering, research institutions across
these regions are dedicated to innovating healthcare solutions that adhere to ethical standards while prioritising sustainability,
affordability, and healthcare system benefits.
Date Issued
2024-11
Date Acceptance
2024-08-11
Citation
Bio-Design and Manufacturing, 2024, 7 (6), pp.825-856
ISSN
2096-5524
Publisher
Springer
Start Page
825
End Page
856
Journal / Book Title
Bio-Design and Manufacturing
Volume
7
Issue
6
Copyright Statement
© The Author(s) 2024 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
http://dx.doi.org/10.1007/s42242-024-00316-z
Publication Status
Published
Date Publish Online
2024-10-23